(lp0
S"Why Kythera Biopharmaceuticals, Inc Rocketed Higher Motley Fool - Mar 5, 2015 After reporting positive results in clinical trials, Kythera submitted its filing for FDA approval for ATX-101 last May. In ATX-101's trials, the drug, which is a formulation of a molecule that breaks down fat, visibly reduced the amount of fat under ..."
p1
aS'Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion Bloomberg - Jun 17, 2015 Allergan Plc, the maker of wrinkle treatment Botox, agreed to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion to add treatments for double chins and male pattern baldness.Why Kythera Biopharmaceuticals, Inc. Stock Soared Today - Motley FoolAllergan to Acquire KYTHERA Biopharmaceuticals - PR Newswire '
p2
aS'KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA -- First ... GlobeNewswire  - Jun 19, 2015 WESTLAKE VILLAGE, Calif., June 19, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced the U.S.KYTHERA Soars on $2.1 Billion Buyout Offer from Allergan - Analyst Blog - Nasdaq'
p3
aS'KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors GlobeNewswire  - Jan 5, 2015 WESTLAKE VILLAGE, Calif., Jan. 5, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced that it has named Hollings C. Renton to its Board of Directors.'
p4
aS"Photo Release -- KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA ... GlobeNewswire  - Apr 29, 2015 WESTLAKE VILLAGE, Calif., April 29, 2015  -- KYTHERA Biopharmaceuticals, Inc.  announced today that the U.S.FDA approves Westlake Village company's drug to reduce double-chin fat - Los Angeles TimesFDA approves treatment for fat below the chin - FDA.gov"
p5
aS'Sell Kythera  Stock, Another Biotech Ripoff Investorplace.com - Mar 9, 2015 Kythera Biopharmaceuticals Inc  stock was halted Monday as an independent advisory committee reviewed its double-chin treatment, ATX-101.FDA Panel Backs Kythera Double-Chin Treatment - Wall Street JournalAn Injection That Makes Double Chins Disappear Is Probably Coming Soon - Yahoo Health'
p6
aS'Allergan to buy Kythera Biopharmaceuticals in $2.1 billion deal MarketWatch - Jun 17, 2015 Allergan PLC AGN, -0.24% announced an deal to buy Kythera Biopharmaceuticals Inc. kyth in a cash and stock deal valued at $2.1 billion.'
p7
aS'KYTHERA Biopharmaceuticals Submits Investigational New Drug Application for ... GlobeNewswire  - Sep 22, 2015 WESTLAKE VILLAGE, Calif., Sept. 22, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced it has submitted an Investigational New Drug Application  to the U.S.'
p8
aS"Allergan , KYTHERA Biopharma  Enter Amended Merger; Will Now be All ... StreetInsider.com - Aug 5, 2015 Allergan  and KYTHERA Biopharmaceuticals, Inc.  announced that they have amended and restated their merger agreement with respect to Allergan's pending acquisition of KYTHERA to provide for all-cash consideration to&nbsp;...Allergan Changes Its $2.1 Billion Deal for Kythera to All Cash - Wall Street Journal"
p9
aS'KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual ... GlobeNewswire  - Feb 10, 2015 WESTLAKE VILLAGE, Calif., Feb. 10, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced that it has entered into separate license agreements with Actelion Pharmaceuticals Ltd.Kythera Biophrarma  Enters Hair Loss IP Agreement with Actelion Pharma ... - StreetInsider.com'
p10
a.